The year in cardiology: coronary interventions
█ Current opinion
Authors:
Andreas Baumbach1,2*, Christos V. Bourantas1,2,3, Patrick W. Serruys4,5, William Wijns5
1Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, West Smithfield, London, EC1A 7BE, UK;
2Centre for Cardiovascular Medicine and Devices, William
Harvey Research Institute, Queen Mary University of London, London, UK;
3Institute of Cardiovascular
Sciences, University College London, London, UK;
4International Centre for Circulatory Health, Imperial College London, London, UK; and
5The Lambe Institute for Translational Medicine and Curam, Saolta University
Healthcare Group, National University of Ireland Galway, Galway, Ireland
Received 3 December 2019; revised 16 December 2019; editorial decision 17 December 2019;
accepted 24 December 2019; online publish-ahead-of-print 6 January 2020
Preamble
Percutaneous coronary intervention (PCI) research focuses on the optimization of treatment strategies, the development of novel equipment and pharmacotherapies for improved results, and on risk stratification and identification of high-risk patients that will benefit from emerging therapies targeting atherosclerotic evolution. Over the last year, important clinical studies have been reported that examined the efficacy of different treatment strategies and stent platforms in patients with obstructive coronary artery disease (CAD) and guidelines have been published to provide recommendations about the management of these patients. The aim of this article is to summarize the findings of the pivotal studies published in 2019 and discuss their impact on clinical practice.
ISSUE: CARDIOLOGIA HUNGARICA | 2020 | VOLUME 50, ISSUE 4
click here to read the full article |
click here to read the pdf |